Craig R. Smith

Craig R. Smith

No más puestos en curso

77 años
Health Technology
Consumer Services
Miscellaneous

Perfil

Craig R.
Smith
was the founder of Guilford Pharmaceuticals, Inc. established in 1993, where he held the position of Chairman, President & Chief Executive Officer until 2004.
He is also the founder of Williston Consulting LLC.
Dr. Smith's former jobs include serving as an Independent Director for Adams Diversified Equity Fund, Inc., Director for La Jolla Pharmaceutical Co., Independent Director for Adams Natural Resources Fund, Inc., Independent Director for Assertio Therapeutics, Inc., Chief Operating Officer, Director & Executive VP for Algenol Biofuels, Inc., Senior VP-Business & Market Development for Centocor, Inc., Member of The Johns Hopkins University School of Medicine, and Chief Operating Officer for Algenol LLC.
Dr. Smith's education history includes an undergraduate degree from Sewanee-The University of the South and a doctorate degree from the State University of New York at Buffalo.

Antiguos cargos conocidos de Craig R. Smith.

EmpresasCargoFin
ADAMS NATURAL RESOURCES FUND, INC. Director/Board Member 01/01/2021
Chief Operating Officer 24/10/2015
Chairman 06/05/2009
LA JOLLA PHARMACEUTICAL COMPANY Chairman 31/12/2010
Chief Executive Officer 01/01/2004
Ver el detalle de la experiencia de Craig R. Smith.

Formación de Craig R. Smith.

Sewanee-The University of the South Undergraduate Degree
State University of New York at Buffalo Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Craig R. Smith.

Relaciones

100 +

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas9

Health Technology

Miscellaneous

Health Technology

Miscellaneous

Health Technology

Health Technology

Williston Consulting LLC

Commercial Services

Process Industries

Ver las conexiones de la empresa